KRYSKrystal Biotech, Inc.

Nasdaq krystalbio.com


$ 184.19 $ -1.87 (-1.01 %)    

Friday, 06-Sep-2024 15:59:59 EDT
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 184.19
$ 183.77 x 100
-- x --
-- - --
$ 93.95 - $ 219.34
92,811
na
5.29B
$ 0.93
$ 49.95
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2024 06-30-2024 10-Q
2 05-06-2024 03-31-2024 10-Q
3 02-26-2024 12-31-2023 10-K
4 11-06-2023 09-30-2023 10-Q
5 08-07-2023 06-30-2023 10-Q
6 05-08-2023 03-31-2023 10-Q
7 02-27-2023 12-31-2022 10-K
8 11-07-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 02-28-2022 12-31-2021 10-K
12 11-08-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-04-2020 03-31-2020 10-Q
19 03-10-2020 12-31-2019 10-K
20 11-04-2019 09-30-2019 10-Q
21 08-05-2019 06-30-2019 10-Q
22 05-07-2019 03-31-2019 10-Q
23 03-12-2019 12-31-2018 10-K
24 11-05-2018 09-30-2018 10-Q
25 08-06-2018 06-30-2018 10-Q
26 05-07-2018 03-31-2018 10-Q
27 03-12-2018 12-31-2017 10-K
28 11-13-2017 09-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cantor-fitzgerald-reiterates-overweight-on-krystal-biotech

Cantor Fitzgerald analyst Josh Schimmer reiterates Krystal Biotech (NASDAQ:KRYS) with a Overweight.

 hc-wainwright--co-reiterates-buy-on-krystal-biotech-maintains-221-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a Buy and maintains $221 pric...

 hc-wainwright--co-maintains-buy-on-krystal-biotech-raises-price-target-to-221

HC Wainwright & Co. analyst Joseph Pantginis maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price tar...

 evercore-isi-group-maintains-outperform-on-krystal-biotech-raises-price-target-to-206

Evercore ISI Group analyst Gavin Clark-Gartner maintains Krystal Biotech (NASDAQ:KRYS) with a Outperform and raises the pric...

 citigroup-downgrades-krystal-biotech-to-neutral-raises-price-target-to-204

Citigroup analyst Yigal Nochomovitz downgrades Krystal Biotech (NASDAQ:KRYS) from Buy to Neutral and raises the price target...

 chardan-capital-maintains-buy-on-krystal-biotech-raises-price-target-to-208

Chardan Capital analyst Geulah Livshits maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price target from ...

 hc-wainwright--co-reiterates-buy-on-krystal-biotech-maintains-200-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a Buy and maintains $200 pric...

 krystal-biotech-reiterated-fy24-rd-and-sga-expense-of-150m-175m

Financial Guidance For the year ending December 31, 2024, we continue to anticipate approximately $150 million to $175 million...

 hc-wainwright--co-reiterates-buy-on-krystal-biotech-maintains-200-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a Buy and maintains $200 pric...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION